|
"hsu cc"的相關文件
顯示項目 251-260 / 686 (共69頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2020-03-10 |
Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma
|
Liao, WY;Hsu, CC;Chan, TS;Yen, CJ;Chen, WY;Pan, HW;Tsai, KK |
| 國家衛生研究院 |
2020-02-27 |
Urate-lowering therapy may prevent the development of coronary artery disease in patients with gout
|
Yen, FS;Hsu, CC;Li, HL;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2020-02 |
Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
|
Chen, JF;Chen, HS;Chu, CH;Chuang, LM;Ho, LT;Hsu, CC;Huang, LC; et al. |
| 國家衛生研究院 |
2020-01-21 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS;Yang, YC;Hwu, CM;Wei, JC;Huang, YH;Hou, MC;Hsu, CC |
| 臺大學術典藏 |
2020-01-06T03:08:43Z |
Determination of Laser-Beam Waist Using Photoionization Time-of-Flight Mass-Spectrometer
|
Wang, Crc; Hsu, Cc; Liu, Wy; Tsai, Wc; Tzeng, Wb; JERRY CHENG-CHE HSU |
| 臺大學術典藏 |
2020-01-06T03:08:43Z |
Si-30(p,alpha)al-27 Reaction from Ep=4.90-6.08 Mev
|
Chang, Js; Cheng, Vkc; Lin, Hh; Hsu, Cc; JERRY CHENG-CHE HSU |
| 中山醫學大學 |
2020 |
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
|
Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2020 |
The factors associated with insulin nonpersistence in persons with type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS; Yang, YC; Hwu, CM; Wei, JCC; Huang, YH; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2020 |
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hwu, CM; Hou, MC; Hsu, CC |
顯示項目 251-260 / 686 (共69頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目
|
